CRNX
Crinetics Pharmaceuticals Inc
85.00$
+0.0%
vs. previous close
Closing price · As of: Sep 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 89.7% | 90.4% | 93.8% | 93.5% | 93.6% | 95.9% | 94.8% | 94.4% | 93.7% | 92.3% | 94.4% | 94.1% | |
| 22.3% | 8.6% | 40.5% | 32.3% | 33.8% | 18.4% | 6.9% | 4.2% | 9.3% | 8.9% | 8.2% | 4.2% | |
| 86.5% | 87.9% | 92.1% | 92.2% | 92.0% | 94.4% | 93.6% | 92.8% | 91.3% | 90.5% | 92.1% | 91.2% | |
| 1.8% | 1.5% | 1.0% | 0.5% | 0.7% | 0.6% | 0.5% | – | – | 0.1% | 0.4% | 0.9% | |
| -1.8% | – | – | – | – | 0.0% | – | – | – | 0.2% | 0.2% | 0.3% | |
| 14.6% | 15.1% | 10.6% | 11.2% | 11.1% | 7.7% | 7.9% | 9.2% | 10.4% | 12.6% | 8.6% | 9.8% | |
| 6.3% | 6.9% | 5.3% | 5.8% | 5.7% | 4.2% | 4.2% | 5.3% | 6.2% | 7.5% | 5.1% | 6.0% | |
| 0.6% | 0.7% | 0.6% | 0.8% | 0.8% | 0.5% | 0.5% | 0.5% | 0.5% | 0.6% | 0.5% | 0.5% | |
| 0.9% | 1.0% | 1.1% | 0.9% | 0.5% | 0.4% | 0.7% | 0.9% | 0.5% | 2.0% | 0.9% | 1.0% | |
| 85.4% | 84.9% | 89.4% | 88.8% | 88.9% | 92.3% | 92.1% | 90.8% | 89.6% | 87.4% | 91.4% | 90.2% | |
| -92.5% | -102.9% | -73.7% | -84.9% | -93.0% | -66.4% | -77.0% | -90.3% | -108.2% | -124.8% | -110.3% | -126.0% | |
| 8.9% | 10.6% | 7.4% | 8.4% | 8.5% | 6.4% | 6.8% | 7.3% | 7.9% | 8.3% | 7.4% | 8.0% |
Data as of: September 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.